Assistant Corporate Controller

Company Overview

City Therapeutics is biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine. Co-founded by pioneering industry executives and backed by premier investors, we are rapidly expanding our sustainable product engine, which includes our ongoing Phase 1 clinical trial for CITY-FXI (targeting thromboembolic diseases) and multiple programs advancing toward the clinic.

Position Summary
The Senior Director, Assistant Corporate Controller will report to the Vice President Finance and play a key leadership role in overseeing the Company's accounting operations, financial reporting, and internal controls environment. This individual will be responsible for ensuring accurate and timely financial reporting, maintaining compliance with U.S. GAAP and SEC requirements. Candidates should possess public company experience and the ability to transition systems and processes to support City’s growth.

Key Responsibilities

Financial Reporting and SEC Compliance

• Lead all day-to-day accounting operations, including payroll, accounts payable, cash, and equity administration.
• Deliver accurate, timely, and U.S. GAAP-compliant financial reporting by executing the end-to-end monthly, quarterly, and annual close processes.
• Oversee and own clinical and R&D accruals to ensure audit-ready estimates, alongside leases, fixed assets, and stock-based compensation.
• Coordinate the income tax provision and compliance activities with external advisors, and maintain appropriate support for tax, statutory, and other regulatory requirements.
• Develop and mentor members of the accounting team, fostering a culture consistent with City’s core values.
• Lead the continuous optimization and scaling of financial systems (e.g., NetSuite), ensuring robust automated workflows, segregation of duties, and configuration controls.

Technical Accounting and SEC Reporting

• Serve as primary resource for technical accounting guidance, including leases and stock-based compensation.
• Oversee the technical evaluation and operational accounting for complex business development arrangements, licensing agreements, and co-development partnerships.
• Establish and maintain accounting policies, procedures, and documentation, and ensure that technical conclusions are consistently implemented in the close.
• Preparation and review of SEC filings (e.g. 10-K, 10-Q, DEF 14-A), ensuring accuracy, completeness, and compliance with disclosure requirements.
• Own the review and accuracy of XBRL data tagging and selections for all applicable SEC filings.